Browsing Tag
antiviral drug development
3 posts
AptarGroup partners with Covirix Medical to explore inhalable antivirals for pandemic-potential respiratory viruses
AptarGroup, Inc. and Covirix Medical explore inhalable antivirals targeting pandemic respiratory viruses. Discover the strategy behind the partnership.
Bioxytran reports successful clinical trial for ProLectin-M, a broad-spectrum antiviral targeting multiple respiratory viruses
Find out how Bioxytran’s completed randomized trial for ProLectin-M could redefine the antiviral market and reshape biotech investor sentiment.
Kexing Biopharm secures FDA IND approval for GB05, advancing pediatric RSV treatment
Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) has received Investigational New Drug (IND) approval from the United States…